Are you familiar with cannabidiol (CBD)? Do you find yourself nearly convinced regarding medical marijuana’s curative wonders? If you answer “yes” to these two questions, then it is certainly important that you learn about CBD. This chemical is a buzzword in today’s curative industry, contributing to the unstoppable march toward medical advancements.
The Nature of CBD
In today’s medical scene, medical marijuana is gaining ground with more support since 29 states have cannabis laws already in full implementation. Cannabis, the plant from which marijuana is derived, has been revealed by a number of studies to be a “wonder plant.” Experts have examined cannabis and found plenty of substances which can be the basis for the development of a new cure. Among these chemicals is cannabidiol.
As a component of the cannabis plant, cannabidiol is one of the 85 cannabinoids or compounds nearly making up 40 percent of cannabis extracts. It can be easily extracted because it is an inherent and substantial part of the plant found throughout its flowers, buds, seeds, and stalks.
Nowadays, as research and development regarding CBD abound, a plethora of commercial products in the form of capsules, oil, and syrups can be found in wellness and medical marijuana retail shops.
The Medical Relevance of CBD
CBD is legal nationwide, though the Food and Drug Administration (FDA) has not given the green light to fully consider it as a valid medicine. In spite of the brick-and-mortar stores and Internet shops being awash with CBD merchandise, the FDA has issued warnings against the vendors in 2015 and 2016. The government body is wary of the unsubstantiated medical benefits and dietary supplement claims of the products sold to the public.
The fast-growing CBD industry is defying FDA’s slow approval with new discoveries regarding its restorative effects. Cannabidiol has the potential to treat a vast array of health conditions which include:
|Antibiotic-resistant infections||Depression||Multiple sclerosis||Seizures|
CBD can be taken in orally and by inhalation or nasally (through prescription sprays). It is not a psychoactive drug, so it doesn’t affect the mind or behavior once taken in the body. In addition, euphoric or “high” feelings will not be experienced by patients.
It can be noted that marijuana’s intoxicating “high” is caused by the substance tetrahydrocannabinol or THC, another of the many compounds found in cannabis. On the contrary, CBD users are reportedly reaching relaxed and calm states. CBD’s anti-proliferative and anti-angiogenic properties can also fight cancer and its stages from advancing. As an analgesic, it can help patients suffering from chronic pain.
The Imminent Acceptance of CBD as a Healing Agent
Since marijuana is still a Schedule 1 drug (or, according to the Drug Enforcement Administration, drugs without legitimate medical purpose and that are highly likely to be abused), this also means that cannabidiol, being its derivative, is also classified as such. Nevertheless, the hazy future of CBD as a drug is foreseen to end. The following recent developments will potentially pave the way for its eventual validation as an effective and authentic cure:
- In a 2017 survey jointly conducted by HelloMD, a major medical marijuana online community, and cannabis think-tank Brightfield Group, 80 percent of the participants expressed “very effective” and “extremely effective” regarding CBD’s effect particularly in addressing insomnia and anxiety.
- In a late 2017 report, the World Health Organisation has declared that CBD is not a public health risk and does not possess addictive nor toxic natures. Furthermore, the chief international health bureau stated that the substance is recommended for curing epilepsy and a myriad of other medical conditions. Hence, it does not need to be a government-regulated or scheduled substance.
- In February 2018, an 8-month study performed by Cornell University researchers on dogs led to the conclusion that CBD is effective as a pain reliever.
- In April 2018, the FDA has unanimously approved the cannabis-based medicine for epilepsy called Epidiolex. This drug is effective in treating Dravet syndrome and Lennox-Gastaut syndrome.
Given these developments, CBD’s widespread approval appears to be on the horizon. The FDA as a regulatory body may not be fully convinced yet regarding CBD as a bona fide cure, but the recent events show that it is gradually opening its doors.
Indeed, substantial medical evidence is still required for CBD to progress. But with the acceptance of established groups as well as the multifarious ongoing studies which facilitate greater understanding, various applications, and innovation for CBD, it is only a matter of time that cannabidiol will become widely accepted as completely legitimate medicine.
Until definitive results are available, experts in the industry can give you a walkthrough about everything there is about the cannabidiol industry and its future.